If ERα is a crucial marker of breast cancer diagnosis and a well-known therapeutic target against the disease, it is important to keep in mind that, during a woman’s lifetime, ERα expression in breast tissue does not remain constant, even in a physiological context. Here, ESR1 is linked to breast cancer.